SENSITIVITY OF EYE-MOVEMENT REGISTRATION AND VISUAL EVOKED-POTENTIALS IN EVALUATION OF THERAPY IN PATIENTS WITH MULTIPLE-SCLEROSIS

被引:10
作者
VANDONGEN, MMMM [1 ]
BERTELSMANN, FW [1 ]
POLMAN, CH [1 ]
机构
[1] FREE UNIV AMSTERDAM HOSP,DEPT NEUROL,AMSTERDAM,NETHERLANDS
关键词
EYE MOVEMENTS; VISUAL EVOKED POTENTIALS; MULTIPLE SCLEROSIS; DISEASE ACTIVITY; TREATMENT PROTOCOL; CORTICOSTEROIDS;
D O I
10.1016/0022-510X(91)90089-P
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A major problem in the evaluation of multiple sclerosis (MS) treatment protocols is the lack of an objective and reliable marker of disease activity. In 24 MS patients who were treated with high dose of intravenous methylprednisolone because of an acute relapse or progressive disease the clinical improvement (as measured by the Kurtzke expanded disability status scale) was compared with two paraclinical parameters, i.e. visual evoked potentials (VEP) and the registration of saccadic and smooth pursuit eye movements. After treatment a significant clinical improvement was found in 50% of the patients. The registration of eye movements revealed a significant improvement in 83% of the patients, the VEP in 21%. It is demonstrated that especially the registration of eye movements can have an important application as an objective and sensitive method in the assessment of neurological functions during MS treatment protocols.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 25 条
[1]   INTERRATER RELIABILITY IN ASSESSING FUNCTIONAL-SYSTEMS AND DISABILITY ON THE KURTZKE SCALE IN MULTIPLE-SCLEROSIS [J].
AMATO, MP ;
FRATIGLIONI, L ;
GROPPI, C ;
SIRACUSA, G ;
AMADUCCI, L .
ARCHIVES OF NEUROLOGY, 1988, 45 (07) :746-748
[2]   EVOKED-POTENTIALS TO TEST A TREATMENT OF CHRONIC MULTIPLE-SCLEROSIS [J].
ANDERSON, DC ;
SLATER, GE ;
SHERMAN, R ;
ETTINGER, MG .
ARCHIVES OF NEUROLOGY, 1987, 44 (12) :1232-1236
[3]   INTRAVENOUS METHYLPREDNISOLONE FOR MULTIPLE-SCLEROSIS IN RELAPSE [J].
BARNES, MP ;
BATEMAN, DE ;
CLELAND, PG ;
DICK, DJ ;
WALLS, TJ ;
NEWMAN, PK ;
SAUNDERS, M ;
TILLEY, PJB .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1985, 48 (02) :157-159
[4]  
COMPSTON DAS, 1983, ARCH NEUROL-CHICAGO, V45, P669
[5]   EVALUATION OF EVOKED-POTENTIALS AND LYMPHOCYTE SUBSETS AS POSSIBLE MARKERS OF MULTIPLE-SCLEROSIS - ONE YEAR FOLLOW-UP OF 30 PATIENTS [J].
GHEZZI, A ;
ZAFFARONI, M ;
CAPUTO, D ;
MONTANINI, R ;
CAZZULLO, CL .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1986, 49 (08) :913-919
[6]   SACCADIC EYE-MOVEMENT ANALYSIS AS A MEASURE OF DRUG EFFECTS ON HUMAN PSYCHOMOTOR PERFORMANCE [J].
GRIFFITHS, AN ;
MARSHALL, RW ;
RICHENS, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 :S73-S82
[7]  
KURTZKE J F, 1987, Neuroepidemiology, V6, P17, DOI 10.1159/000110097
[8]   THE DISABILITY STATUS SCALE FOR MULTIPLE-SCLEROSIS - APOLOGIA PRO DSS SUA [J].
KURTZKE, JF .
NEUROLOGY, 1989, 39 (02) :291-302
[9]  
KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
[10]   QUANTITATIVE STUDIES OF SACCADIC AND PURSUIT EYE-MOVEMENTS IN MULTIPLE-SCLEROSIS [J].
MASTAGLIA, FL ;
BLACK, JL ;
COLLINS, DWK .
BRAIN, 1979, 102 (DEC) :817-834